Results 161 to 170 of about 42,366 (268)

Antiarrhythmic drugs for cardiac arrest with a shockable rhythm and their effect on outcomes: a systematic review with meta-analysis. [PDF]

Europace
Schnaubelt S, Veigl C, Kornfehl A, Brock R, Tapinova K, Krammel M, Wildner B, Sossalla S, Niessner A, Sulzgruber P.   +9 more
europepmc   +1 more source

Proarrhythmia associated with antiarrhythmic drugs: a comprehensive disproportionality analysis of the FDA adverse event reporting system. [PDF]

Front Pharmacol, 2023
Wang F, Zhou B, Sun H, Wu X.
europepmc   +1 more source

Successful Management of Fetal Supraventricular Tachycardia With Flecainide in a Case Complicated by Early Hydrops Fetalis: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Fetal arrhythmia that can lead to hydrops fetalis and fetal heart failure if untreated. This case report describes the successful treatment of a fetus with SVT at 26 weeks of gestation using flecainide. A 37‐year‐old gravida 3, para 2 woman was diagnosed with fetal SVT during a routine ultrasound, which also revealed mild pleural effusion ...
Amirabbas Faridpour, Yazdan Ghandi, Alireza Golbabaei   +2 more
wiley   +1 more source

Catheter ablation vs antiarrhythmic drugs for persistent atrial fibrillation in hypertrophic cardiomyopathy. [PDF]

Heart Rhythm O2
Shahrori Z, Rayyan A, Sharma S, Sallam L, Arruda M, Mackall J, Sharma E.   +6 more
europepmc   +1 more source

Flecainide‐Induced Interstitial Lung Disease: A Case Report and Review of the Literature

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT This case describes a rare adverse effect in which the subject developed interstitial lung disease after initiating a class IC antiarrhythmic, flecainide. There is no current treatment recommendation for flecainide‐induced interstitial lung disease.
Elizabeth Jenkins, John McGinty, Brian Skinner   +2 more
wiley   +1 more source

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study. [PDF]

Br J Clin Pharmacol
Meinert FM, Dimakos J, Cui Y, Filion KB, Renoux C, Douros A.   +5 more
europepmc   +1 more source

Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials. [PDF]

Front Cardiovasc Med, 2023
Chen G, Li G, Zhang D, Wang X, Guo X.
europepmc   +1 more source

Possible Deslanoside‐Induced Left Posterior Fascicular Ventricular Tachycardia: A Case Report

Annals of Noninvasive Electrocardiology, Volume 31, Issue 3, May 2026.
A 73‐year‐old man with paroxysmal AF and no structural heart disease who developed left posterior fascicular ventricular tachycardia (LPFVT) shortly after intravenous Deslanoside administration for rate control. Highlights: cardiac glycosides, though effective for rate control, may occasionally precipitate Purkinje‐related ventricular tachycardia ...
Zhang Wenjun, Chen Yao
wiley   +1 more source

Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies. [PDF]

Eur J Clin Pharmacol
Meinert FM, Dimakos J, Riemer TG, Douros A.   +3 more
europepmc   +1 more source

Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function. [PDF]

Crit Care Explor, 2023
Driscoll DF, Welty FK, Bistrian BR.
europepmc   +1 more source